Payment overview · 2025
General Payments
$87.76
4 reported records · 4 companies
Healthcare provider profile · identity verified
Ramakrishna V Chava, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · KINGWOOD, TX · NPI 1790998706
Verified facts
What the public records show
CMS Open Payments records show Ramakrishna V Chava, M.D. received $87.76 in general payments during 2025 across 4 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 30.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti, Xifaxan.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Rexulti by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Xifaxan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $26.81 | 30.6% | 1 | 2025 |
| KYOWA KIRIN, INC. | Unresolved — no canonical attribution shown | $23.37 | 26.6% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $21.67 | 24.7% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $15.91 | 18.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $87.76 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $26.81 | 1 | 2025 |
Source payment records
|
|||||
| CRYSVITA Normalized: crysvita |
Drug | KYOWA KIRIN, INC. | $23.37 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $21.67 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.91 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 51 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
51 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1452 | 324 |
| Levothyroxine Sodium | Levothyroxine Sodium | 756 | 156 |
| Furosemide | Furosemide | 753 | 194 |
| Eliquis | Apixaban | 695 | 123 |
| Amlodipine Besylate | Amlodipine Besylate | 656 | 180 |
| Gabapentin | Gabapentin | 579 | 172 |
| Gemtesa | Vibegron | 504 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 494 | 217 |
| Metformin Hcl | Metformin Hcl | 489 | 111 |
| Carvedilol | Carvedilol | 486 | 103 |
| Losartan Potassium | Losartan Potassium | 457 | 102 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 414 | 103 |
| Lisinopril | Lisinopril | 401 | 109 |
| Potassium Chloride | Potassium Chloride | 396 | 96 |
| Donepezil Hcl | Donepezil Hcl | 391 | 68 |
| Tamsulosin Hcl | Tamsulosin Hcl | 355 | 103 |
| Metoprolol Tartrate | Metoprolol Tartrate | 354 | 118 |
| Clopidogrel | Clopidogrel Bisulfate | 351 | 107 |
| Divalproex Sodium | Divalproex Sodium | 348 | 47 |
| Trazodone Hcl | Trazodone Hcl | 340 | 72 |
| Nifedipine Er | Nifedipine | 338 | 81 |
| Mirtazapine | Mirtazapine | 326 | 67 |
| Sertraline Hcl | Sertraline Hcl | 285 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 265 | 57 |
| Hydralazine Hcl | Hydralazine Hcl | 260 | 53 |
| Memantine Hcl | Memantine Hcl | 255 | 51 |
| Prednisone | Prednisone | 251 | 112 |
| Levetiracetam | Levetiracetam | 234 | 54 |
| Tramadol Hcl | Tramadol Hcl | 234 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 222 | 87 |
| Xarelto | Rivaroxaban | 211 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 194 | 63 |
| Famotidine | Famotidine | 193 | 48 |
| Allopurinol | Allopurinol | 192 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 174 | 43 |
| Duloxetine Hcl | Duloxetine Hcl | 162 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 162 | 40 |
| Buspirone Hcl | Buspirone Hcl | 159 | 37 |
| Montelukast Sodium | Montelukast Sodium | 146 | 42 |
| Finasteride | Finasteride | 139 | 31 |
| Omeprazole | Omeprazole | 126 | 44 |
| Lorazepam | Lorazepam | 125 | 33 |
| Azithromycin | Azithromycin | 122 | 87 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 118 | 83 |
| Pregabalin | Pregabalin | 114 | 18 |
| Spironolactone | Spironolactone | 114 | 31 |
| Klor-Con M20 | Potassium Chloride | 109 | 23 |
| Clonidine Hcl | Clonidine Hcl | 108 | 47 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 107 | 35 |
| Trulicity | Dulaglutide | 105 | 19 |
| Alprazolam | Alprazolam | 102 | 26 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 102 | 18 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 101 | 31 |
| Baclofen | Baclofen | 99 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 98 | 24 |
| Simvastatin | Simvastatin | 98 | 29 |
| Amiodarone Hcl | Amiodarone Hcl | 95 | 52 |
| Sucralfate | Sucralfate | 95 | 43 |
| Entresto | Sacubitril/Valsartan | 94 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 90 | 29 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 86 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 85 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 85 | 34 |
| Humalog Kwikpen U-100 | Insulin Lispro | 85 | 29 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 84 | 49 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 81 | 45 |
| Midodrine Hcl | Midodrine Hcl | 80 | 41 |
| Cephalexin | Cephalexin | 79 | 64 |
| Jardiance | Empagliflozin | 79 | 15 |
| Levofloxacin | Levofloxacin | 79 | 40 |
| Fluoxetine Hcl | Fluoxetine Hcl | 76 | 16 |
| Temazepam | Temazepam | 76 | 11 |
| Fenofibrate | Fenofibrate | 75 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 75 | 52 |
| Bumetanide | Bumetanide | 74 | 23 |
| Enalapril Maleate | Enalapril Maleate | 73 | suppressed |
| Meloxicam | Meloxicam | 73 | 33 |
| Methocarbamol | Methocarbamol | 72 | 41 |
| Alendronate Sodium | Alendronate Sodium | 71 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 71 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 71 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 71 | 43 |
| Imipenem-Cilastatin Sodium | Imipenem/Cilastatin Sodium | 69 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 69 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 66 | suppressed |
| Nystatin | Nystatin | 66 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 65 | 17 |
| Sodium Chloride | 0.9 % Sodium Chloride | 65 | 41 |
| Risperidone | Risperidone | 64 | 16 |
| Leflunomide | Leflunomide | 63 | suppressed |
| Tradjenta | Linagliptin | 63 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 59 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 58 | 34 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 57 | 15 |
| Labetalol Hcl | Labetalol Hcl | 55 | suppressed |
| Glipizide | Glipizide | 53 | 17 |
| Ozempic | Semaglutide | 53 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 49 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 18 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 51 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 51 | 15 |
| Xifaxan | Rifaximin | 51 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | 12 |
| Novolog Flexpen | Insulin Aspart | 50 | 15 |
| Atenolol | Atenolol | 49 | suppressed |
| Digoxin | Digoxin | 45 | 15 |
| Ceftriaxone | Ceftriaxone Sodium | 44 | 25 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 44 | suppressed |
| Lactulose | Lactulose | 44 | 28 |
| Meropenem | Meropenem | 44 | 17 |
| Torsemide | Torsemide | 44 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 43 | suppressed |
| Januvia | Sitagliptin Phosphate | 42 | suppressed |
| Latanoprost | Latanoprost | 42 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 41 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 41 | 22 |
| Nystop | Nystatin | 41 | 27 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 41 | 29 |
| Megestrol Acetate | Megestrol Acetate | 40 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Lamotrigine | Lamotrigine | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 37 | suppressed |
| Ibuprofen | Ibuprofen | 37 | suppressed |
| Methimazole | Methimazole | 37 | suppressed |
| Amoxicillin | Amoxicillin | 36 | 27 |
| Glimepiride | Glimepiride | 36 | 11 |
| Lovastatin | Lovastatin | 36 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 36 | 11 |
| Promethazine Hcl | Promethazine Hcl | 36 | 18 |
| Clonazepam | Clonazepam | 35 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | 14 |
| Mupirocin | Mupirocin | 35 | 31 |
| Olanzapine | Olanzapine | 35 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 34 | suppressed |
| Ezetimibe | Ezetimibe | 34 | 13 |
| Budesonide | Budesonide | 33 | 15 |
| Aripiprazole | Aripiprazole | 32 | suppressed |
| Calcitriol | Calcitriol | 31 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 31 | 28 |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Rexulti | Brexpiprazole | 30 | suppressed |
| Enulose | Lactulose | 29 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | 11 |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 28 | 15 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 28 | 19 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 28 | 16 |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Humalog | Insulin Lispro | 27 | 11 |
| Ingrezza | Valbenazine Tosylate | 27 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 22 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 26 | 26 |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | 13 |
| Lidocaine Hcl | Lidocaine Hcl | 26 | 19 |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | 15 |
| Hydrocortisone | Hydrocortisone | 25 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Topiramate | Topiramate | 25 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Acetylcysteine | Acetylcysteine | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 24 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Brilinta | Ticagrelor | 22 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Cefdinir | Cefdinir | 22 | 22 |
| Fluconazole | Fluconazole | 22 | 19 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Metronidazole | Metronidazole | 22 | 17 |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 21 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Rivastigmine | Rivastigmine | 20 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 14 |
| Colchicine | Colchicine | 19 | 13 |
| Haloperidol | Haloperidol | 19 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Sulfasalazine | Sulfasalazine | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Misoprostol | Misoprostol | 18 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 18 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Nicardipine Hcl | Nicardipine Hcl | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 16 | 11 |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Clonidine | Clonidine | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Lacosamide | Lacosamide | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 13 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Travoprost | Travoprost | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Dexamethasone | Dexamethasone | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 11 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 13 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 13 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 13 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Dovato | Dolutegravir Sodium/Lamivudine | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Fluvoxamine Maleate Er | Fluvoxamine Maleate | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Levoxyl | Levothyroxine Sodium | 11 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Rifampin | Rifampin | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $87.76 · 4 records | Otsuka America Pharmaceutical, Inc. | CRYSVITA, REXULTI, VOQUEZNA, XIFAXAN | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error